文献速递免疫规划妇幼与学校卫生

自闭症谱系障碍儿童接种麻疹和百日咳疫苗的安全性

Safety of measles and pertussis-containing vaccines in children with autism spectrum disorders.
PubMed 文献 · Vaccine · 2022-03-18

研究纳入1995-2012年出生、接种时4-7岁的儿童,比较自闭症谱系障碍(ASD)儿童与非ASD儿童接种含麻疹或百日咳疫苗后发热、热性惊厥和急诊就诊风险。结果显示ASD儿童接种后发热和急诊就诊风险未增加,含百日咳疫苗在非ASD儿童中与热性惊厥小幅风险升高相关。

要点

  • ASD儿童接种含麻疹或百日咳疫苗后发热风险与非ASD儿童无差异。
  • ASD儿童接种后急诊就诊风险与非ASD儿童无差异。
  • 含百日咳疫苗在非ASD儿童中与热性惊厥小幅风险升高相关。

核心结论

  • ASD儿童接种含麻疹或百日咳疫苗后发热或急诊就诊风险未较非ASD儿童增加。
  • 这些结果可能进一步表明这些疫苗对所有儿童(包括ASD儿童)是安全的。

研究设计与样本

  • 研究纳入1995-2012年出生、接种时4-7岁、疫苗安全数据链(Vaccine Safety Datalink)内六个医疗系统的成员。
  • 采用自身对照风险区间分析,比较各ASD状态组内风险区间与对照区间的结局率,并用逻辑回归估计双重差分比较ASD与非ASD儿童的风险区间和对照区间结局率。
  • 研究纳入14,947名ASD儿童和1,650,041名非ASD儿童。

主要发现

  • 接种含麻疹疫苗后发热的率比之比=1.07(95%CI 0.58-1.96),ASD与非ASD儿童无差异。
  • 接种含百日咳疫苗后发热的率比之比=1.16(95%CI 0.63-2.15),ASD与非ASD儿童无差异。
  • 接种含麻疹疫苗后急诊就诊的率比之比=1.11(95%CI 0.80-1.54),ASD与非ASD儿童无差异。
  • 接种含百日咳疫苗后急诊就诊的率比之比=0.87(95%CI 0.59-1.28),ASD与非ASD儿童无差异。
  • 热性惊厥罕见,含百日咳疫苗在非ASD儿童中与热性惊厥小幅风险升高相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To determine whether children aged 4-7 years with a diagnosis of autism spectrum disorders (ASD) were at increased risk of fever, febrile seizures, or emergency department (ED) visits following measles- or pertussis-containing vaccines compared with children without ASD. METHODS: The study included children born between 1995-2012, aged 4-7 years at vaccination, and members of six healthcare delivery systems within Vaccine Safety Datalink. We conducted self-controlled risk interval analyses comparing rates of outcomes in risk and control intervals within each group defined by ASD status, and then compared outcome rates between children with and without ASD, in risk and control intervals, by estimating difference-in-differences using logistic regressions. RESULTS: The study included 14,947 children with ASD and 1,650,041 children without ASD. After measles- or pertussis-containing vaccination, there were no differences in association between children with and without ASD for fever (ratio of rate ratio for measles-containing vaccine = 1.07, 95% CI 0.58-1.96; for pertussis-containing vaccine = 1.16, 95% CI 0.63-2.15) or ED visits (ratio of rate ratio for measles-containing vaccine = 1.11, 95% CI 0.80-1.54; for pertussis-containing vaccine = 0.87, 95% CI 0.59-1.28). Febrile seizures were rare. Pertussis-containing vaccines were associated with small increased risk of febrile seizures in children without ASD. CONCLUSION: Children with ASD were not at increased risk for fever or ED visits compared with children without ASD following measles- or pertussis-containing vaccines. These results may provide further reassurance that these vaccines are safe for all children, including those with ASD.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Zerbo O, Modaressi S, Goddard K, et al. Safety of measles and pertussis-containing vaccines in children with autism spectrum disorders. Vaccine. 2022. PMID: 35315325. doi:10.1016/j.vaccine.2022.03.031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。